NO20082003L - Vaksiner og fremgangsmåter for behandling av hundeinfluensa - Google Patents

Vaksiner og fremgangsmåter for behandling av hundeinfluensa

Info

Publication number
NO20082003L
NO20082003L NO20082003A NO20082003A NO20082003L NO 20082003 L NO20082003 L NO 20082003L NO 20082003 A NO20082003 A NO 20082003A NO 20082003 A NO20082003 A NO 20082003A NO 20082003 L NO20082003 L NO 20082003L
Authority
NO
Norway
Prior art keywords
vaccines
methods
canine influenza
treating canine
treating
Prior art date
Application number
NO20082003A
Other languages
English (en)
Inventor
Shelly Lynn Shields
Hans Anthony Draayer
Michael John Huether
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20082003L publication Critical patent/NO20082003L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/828—Bacterial vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20082003A 2005-10-07 2008-04-28 Vaksiner og fremgangsmåter for behandling av hundeinfluensa NO20082003L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72482705P 2005-10-07 2005-10-07
PCT/IB2006/002741 WO2007042884A1 (en) 2005-10-07 2006-09-25 Vaccines and methods to treat canine influenza

Publications (1)

Publication Number Publication Date
NO20082003L true NO20082003L (no) 2008-06-24

Family

ID=37684915

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082003A NO20082003L (no) 2005-10-07 2008-04-28 Vaksiner og fremgangsmåter for behandling av hundeinfluensa

Country Status (18)

Country Link
US (2) US7722884B2 (no)
EP (2) EP1945254A1 (no)
JP (2) JP4667507B2 (no)
KR (2) KR20080042174A (no)
CN (1) CN101309701A (no)
AR (1) AR056566A1 (no)
AU (1) AU2006300927B2 (no)
BR (1) BRPI0616328A2 (no)
CA (1) CA2621320C (no)
ME (1) ME00485B (no)
NO (1) NO20082003L (no)
NZ (1) NZ566490A (no)
PH (1) PH12011502633A1 (no)
RS (1) RS20080138A (no)
RU (1) RU2396976C2 (no)
TW (1) TW200730188A (no)
WO (1) WO2007042884A1 (no)
ZA (1) ZA200802892B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
CN103451158B (zh) * 2005-04-21 2018-11-23 佛罗里达大学研究基金公司 用于犬科动物中呼吸系统疾病控制的物质和方法
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7468187B2 (en) 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
EP1941033A2 (en) * 2005-10-20 2008-07-09 Wyeth a Corporation of the State of Delaware Compositions and methods for the treatment of canine influenza virus disease
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
WO2008070332A2 (en) * 2006-10-25 2008-06-12 Intervet International B.V. Feline influenza vaccine and method of use
KR101099883B1 (ko) 2006-12-27 2011-12-28 화이자 프로덕츠 인코포레이티드 백신 투여 방법
GB0705245D0 (en) * 2007-03-19 2007-04-25 Stabilitech Ltd Stable biological products
KR20100075462A (ko) * 2007-09-10 2010-07-02 인터벳 인터내셔널 비.브이. 개, 고양이 및 말의 인플루엔자 감염을 예방하기 위한 조성물 및 방법
KR100850545B1 (ko) * 2007-10-30 2008-08-05 주식회사 에니멀제네틱스 신규한 개 인플루엔자 바이러스 및 이의 백신
ES2728949T3 (es) * 2008-06-27 2019-10-29 Zoetis Services Llc Composiciones adyuvantes novedosas
US20110110975A1 (en) * 2009-11-06 2011-05-12 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
RU2586294C2 (ru) 2010-03-10 2016-06-10 Интервет Интернэшнл Б.В. Способ защиты от заболеваний, вызываемых вторичными патогенами
CN101892200B (zh) * 2010-03-18 2012-05-30 中国农业科学院哈尔滨兽医研究所 抗h3n8亚型马流感病毒单克隆抗体及其用途
BR112013015009B1 (pt) * 2010-12-22 2020-11-10 Intervet International B.V vacina para proteger um animal contra uma doença clínica decorrente de uma infecção com bordetella bronchiseptica
JP5833144B2 (ja) * 2011-02-04 2015-12-16 ゾエティス・エルエルシー イヌ呼吸器病症候群のための組成物
JP5833145B2 (ja) * 2011-02-04 2015-12-16 ゾエティス・エルエルシー 免疫原性ｂｏｒｄｅｔｅｌｌａｂｒｏｎｃｈｉｓｅｐｔｉｃａ組成物
MX385188B (es) 2011-03-14 2025-03-14 Boehringer Ingelheim Vetmedica Inc Vacuna de rinitis equina.
WO2012151391A2 (en) 2011-05-04 2012-11-08 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
US9347065B2 (en) 2012-03-29 2016-05-24 International Aids Vaccine Initiative Methods to improve vector expression and genetic stability
US10555998B2 (en) 2014-11-24 2020-02-11 Intervet Inc. Inactivated equine influenza virus vaccines
CA2995382A1 (en) 2015-08-20 2017-02-23 University Of Rochester Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus
US10973903B2 (en) 2015-08-20 2021-04-13 University Of Rochester NS1 truncated virus for the development of canine influenza vaccines
WO2017031408A1 (en) * 2015-08-20 2017-02-23 University Of Rochester Single-cycle virus for the development of canine influenza vaccines
CN105999257A (zh) * 2016-05-11 2016-10-12 长春海基亚生物技术股份有限公司 无针注射流感疫苗系统与应用
CN109414488A (zh) 2016-06-03 2019-03-01 罗切斯特大学 马流感病毒减毒活疫苗
CN111989116A (zh) 2018-02-27 2020-11-24 罗切斯特大学 用于预防和控制马的马流感病毒(eiv)的多价减毒活流感疫苗

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
DK166762B1 (da) 1986-01-14 1993-07-12 Nederlanden Staat Fremgangsmaade til fremstilling af immunogenkomplekser og farmaceutisk sammensaetning indeholdende saadanne komplekser
EP1279401B1 (en) * 1997-09-05 2008-01-09 GlaxoSmithKline Biologicals S.A. Oil in water emulsions containing saponins
US6051239A (en) 1997-10-20 2000-04-18 Thomas Jefferson University Compositions and methods for systemic delivery of oral vaccines and therapeutic agents
US6482414B1 (en) * 1998-08-13 2002-11-19 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6177082B1 (en) * 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
GB0217434D0 (en) 2002-07-27 2002-09-04 Royal Vetinary College Biological material
US7629440B2 (en) * 2002-08-20 2009-12-08 Genitrix, Llc Lectin compositions and methods for modulating an immune response to an antigen
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
US7572620B2 (en) * 2005-01-11 2009-08-11 Wisconsin Alumni Research Foundation H3 equine influenza A virus
EP1855713B1 (en) 2005-02-15 2016-04-27 Mount Sinai School of Medicine Genetically engineered equine influenza virus and uses thereof
WO2006113214A2 (en) * 2005-04-11 2006-10-26 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Vaccine against pandemic strains of influenza viruses
CN103451158B (zh) * 2005-04-21 2018-11-23 佛罗里达大学研究基金公司 用于犬科动物中呼吸系统疾病控制的物质和方法
CA2616122A1 (en) * 2005-07-20 2007-01-25 Zymogenetics, Inc. Il28 and il29 truncated cysteine mutants and antiviral methods of using same
GB0517293D0 (en) 2005-08-24 2005-10-05 Cancer Rec Tech Ltd Vectors and uses thereof
US7425336B2 (en) * 2005-08-25 2008-09-16 Mevial Limited Canine influenza vaccines
US7384642B2 (en) * 2005-08-25 2008-06-10 Merial Limited Canine influenza vaccines
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
EP1941033A2 (en) * 2005-10-20 2008-07-09 Wyeth a Corporation of the State of Delaware Compositions and methods for the treatment of canine influenza virus disease

Also Published As

Publication number Publication date
KR20080042174A (ko) 2008-05-14
JP2009298802A (ja) 2009-12-24
ZA200802892B (en) 2009-01-28
RU2008113207A (ru) 2009-10-10
US7722884B2 (en) 2010-05-25
JP4667507B2 (ja) 2011-04-13
RU2396976C2 (ru) 2010-08-20
WO2007042884A1 (en) 2007-04-19
CN101309701A (zh) 2008-11-19
EP2452693A3 (en) 2012-06-06
JP2009511464A (ja) 2009-03-19
US7879336B2 (en) 2011-02-01
US20070082012A1 (en) 2007-04-12
US20080254063A1 (en) 2008-10-16
RS20080138A (sr) 2009-07-15
NZ566490A (en) 2011-06-30
CA2621320C (en) 2016-05-24
EP2452693A2 (en) 2012-05-16
PH12011502633A1 (en) 2012-11-12
WO2007042884A9 (en) 2008-05-29
BRPI0616328A2 (pt) 2011-06-14
ME00485B (me) 2011-10-10
AR056566A1 (es) 2007-10-10
AU2006300927A1 (en) 2007-04-19
KR20110126726A (ko) 2011-11-23
EP1945254A1 (en) 2008-07-23
CA2621320A1 (en) 2007-04-19
AU2006300927B2 (en) 2010-05-13
TW200730188A (en) 2007-08-16

Similar Documents

Publication Publication Date Title
NO20082003L (no) Vaksiner og fremgangsmåter for behandling av hundeinfluensa
LT2351578T (lt) Vakcinų gavimo būdas
PL2281830T3 (pl) Szczepionka przeciw wirusowi ospy wietrznej i półpaśca
FI20060449A7 (fi) Mammografiamenetelmä ja mammografialaite
EP1943080A4 (en) METHOD AND APPARATUS FOR BLOW MOLDING WITH STRETCHING
DK1968631T3 (da) Vaccine
DK1959991T3 (da) Terapeutisk vaccine
DE602006020651D1 (de) Kalibrierverfahren und -vorrichtung
EP1848377A4 (en) APPARATUS AND METHOD FOR ARTHROPLASTY OF THE SHOULDER
CR10571A (es) Vacuna virica recombinante
ATE516817T1 (de) Impfstoffe zur immunisierung gegen helicobacter
FI20085224A0 (fi) Laite ja menetelmä ilman desinfioimiseksi
DE602006011600D1 (de) Audiocodierungseinrichtung und audiocodierungsverfahren
DE602007011198D1 (de) Projektionsvorrichtung und projektionsverfahren
DE602006001473D1 (de) Druckvorrichtung und Druckverfahren
DE602006014957D1 (de) Audiocodierungseinrichtung und audiocodierungsverfahren
DK1942933T3 (da) Hundeinfluenzavacciner
DE602008001839D1 (de) Zeiteinstellungsvorrichtung und Zeiteinstellungsverfahren
DE602006017692D1 (de) Wärmebehandlungsvorrichtung
EP1807116A4 (en) FLU VACCINATION
FI20055682A0 (fi) Läpivientiosa sekä menetelmä
DE602006007889D1 (de) Belichtungsverfahren und -vorrichtung
FI20051175A0 (fi) Menetelmä ja laitteisto kaasun steriloimiseksi
EP1872794A4 (en) NASALE VACCINE
DE602005010102D1 (de) Authentifizierungsverfahren und -vorrichtung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application